206 related articles for article (PubMed ID: 22896210)
1. Energy balance modulates mouse skin tumor promotion through altered IGF-1R and EGFR crosstalk.
Moore T; Beltran L; Carbajal S; Hursting SD; DiGiovanni J
Cancer Prev Res (Phila); 2012 Oct; 5(10):1236-46. PubMed ID: 22896210
[TBL] [Abstract][Full Text] [Related]
2. Dietary energy balance modulation of epithelial carcinogenesis: a role for IGF-1 receptor signaling and crosstalk.
Moore T; Checkley LA; DiGiovanni J
Ann N Y Acad Sci; 2011 Jul; 1229():7-17. PubMed ID: 21793833
[TBL] [Abstract][Full Text] [Related]
3. TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling.
Li S; Bode AM; Zhu F; Liu K; Zhang J; Kim MO; Reddy K; Zykova T; Ma WY; Carper AL; Langfald AK; Dong Z
Carcinogenesis; 2011 May; 32(5):779-85. PubMed ID: 21349818
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin is a potent inhibitor of skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Checkley LA; Rho O; Moore T; Hursting S; DiGiovanni J
Cancer Prev Res (Phila); 2011 Jul; 4(7):1011-20. PubMed ID: 21733825
[TBL] [Abstract][Full Text] [Related]
6. IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma.
Gao L; Wang X; Wang X; Zhang L; Qiang C; Chang S; Ren W; Li S; Yang Y; Tong D; Chen C; Li Z; Song T; Zhi K; Huang C
Oncotarget; 2014 May; 5(9):2562-74. PubMed ID: 24810113
[TBL] [Abstract][Full Text] [Related]
7. Prolidase Stimulates Proliferation and Migration through Activation of the PI3K/Akt/mTOR Signaling Pathway in Human Keratinocytes.
Misiura M; Baszanowska W; Ościłowska I; Pałka J; Miltyk W
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287453
[TBL] [Abstract][Full Text] [Related]
8. Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues.
Moore T; Beltran L; Carbajal S; Strom S; Traag J; Hursting SD; DiGiovanni J
Cancer Prev Res (Phila); 2008 Jun; 1(1):65-76. PubMed ID: 19138937
[TBL] [Abstract][Full Text] [Related]
9. Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.
Borland MG; Krishnan P; Lee C; Albrecht PP; Shan W; Bility MT; Marcus CB; Lin JM; Amin S; Gonzalez FJ; Perdew GH; Peters JM
Carcinogenesis; 2014 Jul; 35(7):1602-12. PubMed ID: 24639079
[TBL] [Abstract][Full Text] [Related]
10. Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy.
Brevet M; Shimizu S; Bott MJ; Shukla N; Zhou Q; Olshen AB; Rusch V; Ladanyi M
J Thorac Oncol; 2011 May; 6(5):864-74. PubMed ID: 21774103
[TBL] [Abstract][Full Text] [Related]
11. IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression.
Ford NA; Nunez NP; Holcomb VB; Hursting SD
Endocr Relat Cancer; 2013 Feb; 20(1):39-51. PubMed ID: 23152442
[TBL] [Abstract][Full Text] [Related]
12. Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels.
Moore T; Carbajal S; Beltran L; Perkins SN; Yakar S; Leroith D; Hursting SD; Digiovanni J
Cancer Res; 2008 May; 68(10):3680-8. PubMed ID: 18483250
[TBL] [Abstract][Full Text] [Related]
13. Activation of epidermal akt by diverse mouse skin tumor promoters.
Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
[TBL] [Abstract][Full Text] [Related]
14. Selenium modulates AR/IGF-1R/EGFR and TROP2 signaling pathways and improves anticancer efficacy in murine mammary carcinoma 4T1.
Guo CH; Wang SY; Chung CH; Shih MY; Li WC; Chen PC; Lee SY; Hsia S
J Nutr Biochem; 2023 Oct; 120():109417. PubMed ID: 37482256
[TBL] [Abstract][Full Text] [Related]
15. Ridaforolimus (MK-8669) synergizes with Dalotuzumab (MK-0646) in hormone-sensitive breast cancer.
Becker MA; Hou X; Tienchaianada P; Haines BB; Harrington SC; Weroha SJ; Sathyanarayanan S; Haluska P
BMC Cancer; 2016 Oct; 16(1):814. PubMed ID: 27765027
[TBL] [Abstract][Full Text] [Related]
16. Activation of P2X(7)-mediated apoptosis Inhibits DMBA/TPA-induced formation of skin papillomas and cancer in mice.
Fu W; McCormick T; Qi X; Luo L; Zhou L; Li X; Wang BC; Gibbons HE; Abdul-Karim FW; Gorodeski GI
BMC Cancer; 2009 Apr; 9():114. PubMed ID: 19379509
[TBL] [Abstract][Full Text] [Related]
17. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
18. The IGF-1/IGF-1R signaling axis in the skin: a new role for the dermis in aging-associated skin cancer.
Lewis DA; Travers JB; Somani AK; Spandau DF
Oncogene; 2010 Mar; 29(10):1475-85. PubMed ID: 19966862
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic mice.
Wilker E; Bol D; Kiguchi K; Rupp T; Beltrán L; DiGiovanni J
Mol Carcinog; 1999 Jun; 25(2):122-31. PubMed ID: 10365914
[TBL] [Abstract][Full Text] [Related]
20. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.
De Angel RE; Conti CJ; Wheatley KE; Brenner AJ; Otto G; Degraffenried LA; Hursting SD
Mol Carcinog; 2013 Jun; 52(6):446-58. PubMed ID: 22290600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]